456663697
19 Sep 2020
United States ImmunoGen Presents Final Data From Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination With Carboplatin and Avastin at ESMO
United states
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.